Concepedia

Author

Jagoda Jasielec

University of Chicago

Also Known As

J Jasielec, J. Jasielec, J.K. Jasielec, Jagoda Jasielec, Jagoda K Jasielec, Jagoda K. Jasielec, Muss, Hyman B.

79

Publications

1.1K

Citations

17

H-Index

41

Concepts

All Affiliations

University of ChicagoUniversity of Chicago Medical CenterPoznan University of Medical SciencesDana-Farber Cancer InstituteSarah Cannon
JJ

About

Jagoda Jasielec is an author at University of Chicago specializing in medicine, immunology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

118

2

Health Sciences

3

3

38

3

Nursing

1

1

13

4

Blood Transplantation

1

1

11

5

Cell Biology

1

1

45

Jagoda Jasielec

×

21

Publications

761

Citations

14

H-Index

YearCitations

Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults

Benjamin A. Derman, Keriann Kordas, Jean Ridgeway,

Blood Advances

2019

94

Updated Results from the Phase I CRB-402 Study of Anti-Bcma CAR-T Cell Therapy bb21217 in Patients with Relapsed and Refractory Multiple Myeloma: Correlation of Expansion and Duration of Response with T Cell Phenotypes

Melissa Alsina, Nina Shah, Noopur Raje,

Blood

2020

83

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

Jagoda Jasielec, Tadeusz Kubicki, Noopur Raje,

Blood

2020

72

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma

Andrzej Jakubowiak, Jagoda Jasielec, Cara A. Rosenbaum,

British Journal of Haematology

2019

67

Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy

Jesús G. Berdeja, Melissa Alsina, Nina Shah,

Blood

2019

67

Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis

Benjamin A. Derman, Jagoda Jasielec, Spencer S. Langerman,

Blood Cancer Journal

2020

66

Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor

Shaun Rosebeck, Mattina M. Alonge, Malathi Kandarpa,

Molecular Cancer Therapeutics

2015

45

Final Results of a Phase 2 Trial of Extended Treatment (tx) with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (KRd) Plus Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM)

Todd M. Zimmerman, Noopur Raje, Ravi Vij,

Blood

2016

45

Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent

Benjamin A. Derman, Ankit Kansagra, Jeffrey A. Zonder,

JAMA Oncology

2022

35

Initiation of Aspirin Therapy Modulates Angiogenic Protein Levels in Women with Breast Cancer Receiving Tamoxifen Therapy

Christopher Holmes, Jagoda Jasielec, Jamie E. Levis,

Clinical and Translational Science

2013

34

Page 1